insights_auto
Why is CSJA down 4,17%?
Dive Deeperchevron_right
CSJA:FRA
CSL ADR
27,60 €
arrow_downward
-4,17%(-1,20) 1D
18 նոյ, 08:06:43 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSJA...
Open
27,60 €
High
27,60 €
Low
27,60 €
Mkt. cap
95,68 մլրդ
Avg. vol.
0,00
Volume
40,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 հզր
Open
27,60 €
High
27,60 €
Low
27,60 €
Mkt. cap
95,68 մլրդ
Avg. vol.
0,00
Volume
40,00
52-wk high
43,40 €
52-wk low
12,70 €
No. of employees
29 հզր
News stories
From web sources and news partners
Kalkine
·
2 ժամ առաջ
CSL (ASX:CSL) Shares Gain 11% Over a Year. What Should Investors Watch in the Restructuring?
The Motley Fool Australia
·
14 ժամ առաջ
At $199, are CSL shares a bargain buy or a risky investment?
Yahoo Finance Australia
·
15 ժամ առաջ
CSL’s MV Yampu Named 2026 Bulk Ship of the Year at IBJ Awards
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL ADR
CEOPaul McKenzie
Employees29 հզր
Founded1916
HeadquartersՄելբուրն, Վիկտորիա, Ավստրալիա
SectorHealth Care
Industry-
Websitecsl.com